In summary, we determined that upregulation of MKP-1 significantly inhibits the amyloidogenic processing of APP by regulating the ERK/MAPK signaling pathway, reduces the senile plaque number and ameliorates cognitive function in a mouse model of AD model. The gene discussed is APP; the disease is Alzheimer disease.